Team:INSA-UPS France/Entrepreneurship/Testimonies
iGEM UPS-INSA Toulouse 2017
In order to achieve the most real entrepreneurship approach possible, we first met with some professionals to talk about our idea and get advice to better integrate our system into the cholera market. The people we get in touch with have knowledge in the areas of business development, support for creation of start-ups and about the daily life of villages affected by cholera. We also took into account the feelings of the western population with respect to our project.
Marc Lemonnier is the founding CEO of ANTABIO. This start-up, based at Labège (France) is a private biopharmaceutical company developing novel therapies to treat drug-resistant infections by the most critical Gram-negative pathogens.
To set up a business from an idea, you must be able to answer the problem of the “man in the street”. It is not easy to implement an advanced technology in the developing world. The device will have to be as user friendly as possible.
The steps to follow to ensure a permanent business are:
Pierre Monsan is the founding CEO of TWB (Toulouse White Biotechnology) and Véronique Paquet is the External Relations Director. This is a preindustrial demonstrator whose goal is to speed up the development of industrial biotechnology by facilitating exchanges between public research and industry. It contributes to the expansion of a bioeconomy based on the use of renewable carbon in the fields of chemistry, materials and energy.
We are proud to have submitted our project to TWB which is an entity helping many companies and research projects in their development. TWB is also one of our biggest sponsors, helping us to get the scientific equipment we needed during the iGEM competition to allow our project to start in the best conditions. They proposed to us to get in touch with business developers, an ethicist and industrials. Then, as part of the development of a start-up for our project, TWB could, for example, provide us with premises and equipment.
In addition, we participated to the preparation of the application for the status of "Jeune Entreprise Innovante" (which can be translated as "Young Innovative Company") for Sunwaterlife. This status is very popular among SMEs because, in exchange for an R&D investment of 15% of the tax-deductible expenses for the current year, the company benefits from tax concessions and exemptions from social contributions.
Therefore, this investment and collaboration between our team and Sunwaterlife enabled them to apply to a very interesting status for the start-up.
Claire Salvador is the head manager in charge of the NGO MSF Midi-Pyrénées based in Toulouse. Created in 1971, Médecins Sans Frontières (or Doctors Without Borders) is a humanitarian association that provides medical assistance to populations confronted with of armed conflicts, epidemics, pandemics, natural disasters, etc.
With her experience in the field, Claire Salvador explained that the main problems of cholera are not in villages where the disease is endemic because the population knows perfectly the symptoms and water treatment facilities are increasingly installed. Moreover, countries affected by cholera hide epidemics from tourists to avoid scaring them. Our system should therefore not target the populations accustomed to this disease, nor tourists. However, it would be interesting to adapt it to remote villages, which have a difficult access to the cholera camps and do not necessarily take the time to boil water before using it. The portable and simple aspects of our device are advantages.
Francisco Luquero has a PhD in Infectious disease epidemiology. He has worked on vaccine to prevent cholera. With Epicentre of MSF but also the WHO and UNICEF, Dr Luquero has performed field evaluation of cholera outbreak in Africa. He is also part of the Surveillance OCV Working Groups of the WHO Global Task Force for Cholera Control.
Thanks to his field experience he confirmed what we have learned so far on cholera epidemy. Indeed, he told us that current solutions to avoid cholera infection are not adapted to African’s people’s way of life because they are too expensive and time-expensive. Because he is an expert in biology we were able to explain to him our project. He was surprised to hear that european students may care about cholera and told us that using GMMs do not seem problematic to be accepted as long as the water’s color and taste do not change. As a matter of fact this information is pretty important for us as we are planning to use diacetyl which smell like butter.
Finally he gave us an important information about our system: people in remote village have different reservoir’s size so our device must be adapted to several liters.
Alama Keita works with UNICEF and is a cholera specialist. He travels between Niger, Nigeria, Cameroon, and Democratic Republic of Congo to manage the cholera outbreaks. Created in 1946, the UNICEF or United Nations International Children's Emergency Fund is an agency of the United Nations that aims at improving the condition of children worldwide.
Creating a solution for remote villages is a great idea. The challenge is to get a system with GMMs accepted by NGOs and villagers. NGOs must prove to their donors that they have total control over the products they use (both on the use and on GMM waste treatment), show their efficiency, show that their costs remain reasonable, etc. Moreover, the treatment capacity of our device must be higher than 1 sachet per 1 liter. Indeed, for a village of 15 families with 7 people each, knowing that each person uses about 15 L of water per day, villagers need 11,025 L of water in a week. The use of 11,025 sachets per week is not suitable, especially with respect to waste management.
The key to success would be to create a system independent of NGOs. Villagers from remote villages should not have to travel to the NGOs camps every day to bring the bags containing GMMs. For example, bleach has the advantage of not leaving waste. To conclude, villagers' information and product accessibility will be essential.
With this survey intended to western population, we wanted to know their opinion about such a system and their expectations if they had to use it. The survey was filled in by 510 persons. Analysis was performed with the help of Sandrine Laguerre using the “R” freeware with packages library (ggplot2) and library (FactoMineR).
The the public is not against the idea of using GMMs to ensure water safety. More than 70% are willing to use this product with more information about it.
Also, it appears that, from an occidental point of view, 1 liter should be the right volume to treat. Most likely, western people refer to the amount of water necessary for a 1 day activity, a hiking trip for example. This number could significantly differ from the requirements of people living in developing countries.
People would also enjoy having a fast and efficient device with drinkable water obtained in less than 15 minutes. They would agree to pay up to 50 euros to get such a device.
Taken together, our data show that western populations could accept our device, therefore so could some members of NGOs. The solution is to be transparent and better communicate on the sciences and technologies behind. People are willing to invest in this system, but only if the speed performances have been optimized.
First of all, we would like to thank all those people we met. These exchanges helped us to identify the approach to follow in order to create a business, the possible partners, and the cholera context in order to develop an application that is as appropriate as possible.
In order to start a business, we first need to have proof of concept, talk to scientific and non-scientific (marketing, ethics, communication, law, etc.) people about it in order to get other feedback and ideas, analyze the market through a business plan and not hesitate to contact actors who are used to assist projects development such as TWB or the CRITT Bio-Industries. We must not hide the negative points of our product but instead provide solutions.
Following discussions with cholera experts, we were advised to target people living in isolated villages. The device we will create must be simple, portable, and as independent as possible from NGOs. Ideally, villagers should manage the system from beginning to end, without assistance.
Thanks to all these feedbacks, we have been able to draw up a scope statement covering all the specific features our system must meet.
Testimonies
Marc Lemonnier
Who is he?
His advice?
Pierre Monsan and Véronique Paquet
Who are they?
Their advice?
Pierre-Alain Hoffmann
Christophe Campéri-Ginestet
Claire Salvador
Who is she?
Her advice?
Francisco Luquero
Who is he?
His advice?
Alama Keita
Who is he?
His advice?
Survey
Content
What did we learn from it?
Conclusion about the testimonies
Application pages
Applied Design
Entrepreneurship
Testimonies
Device Conception
Application pages
Applied Design
Entrepreneurship
Testimonies
Device Conception
